- Home
- SGHT vs EML Comparison
SGHT vs EML Comparison
Compare SGHT & EML Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SGHT
- EML
- Stock Information
- Founded
- SGHT 2011
- EML 1858
- Country
- SGHT United States
- EML United States
- Employees
- SGHT N/A
- EML N/A
- Industry
- SGHT Medical Specialities
- EML Industrial Machinery/Components
- Sector
- SGHT Health Care
- EML Consumer Discretionary
- Exchange
- SGHT Nasdaq
- EML Nasdaq
- Market Cap
- SGHT 179.7M
- EML 144.5M
- IPO Year
- SGHT 2021
- EML N/A
- Fundamental
- Price
- SGHT $4.12
- EML $22.64
- Analyst Decision
- SGHT Buy
- EML
- Analyst Count
- SGHT 8
- EML 0
- Target Price
- SGHT $4.16
- EML N/A
- AVG Volume (30 Days)
- SGHT 120.0K
- EML 7.6K
- Earning Date
- SGHT 08-07-2025
- EML 08-05-2025
- Dividend Yield
- SGHT N/A
- EML 1.93%
- EPS Growth
- SGHT N/A
- EML N/A
- EPS
- SGHT N/A
- EML N/A
- Revenue
- SGHT $76,303,000.00
- EML $269,054,445.00
- Revenue This Year
- SGHT N/A
- EML $1.56
- Revenue Next Year
- SGHT $11.22
- EML $7.00
- P/E Ratio
- SGHT N/A
- EML $12.61
- Revenue Growth
- SGHT N/A
- EML 1.30
- 52 Week Low
- SGHT $2.03
- EML $19.06
- 52 Week High
- SGHT $7.05
- EML $35.03
- Technical
- Relative Strength Index (RSI)
- SGHT 60.97
- EML 46.23
- Support Level
- SGHT $3.11
- EML $22.29
- Resistance Level
- SGHT $4.27
- EML $23.15
- Average True Range (ATR)
- SGHT 0.23
- EML 0.43
- MACD
- SGHT 0.09
- EML -0.06
- Stochastic Oscillator
- SGHT 87.07
- EML 35.20
About SGHT Sight Sciences Inc.
Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. Its Surgical Glaucoma segment's product portfolio features the OMNI Surgical System, a device that facilitates the performance of both canaloplasty and trabeculotomy with a single device and single corneal incision to reduce intraocular pressure in adult patients with primary open-angle glaucoma. The company's Dry Eye segment's product portfolio consists of the TearCare System for ophthalmologists and optometrists. It derives key revenue from the Surgical Glaucoma segment.
About EML Eastern Company (The)
The Eastern Co manages industrial businesses that design, manufacture, and sell engineered solutions to industrial markets. The company manages the financial, operational, and strategic performance of its businesses to increase cash generation, operating earnings, and long-term shareholder value. It operates in the United States and Other Countries and generates the majority of its revenue from the United States.